The U.S. National Institutes of Health (NIH) has announced an immediate reduction of billions of dollars in biomedical research funding. The new policy, aimed at capping indirect costs at 15%, has drawn rapid criticism from scientists and institutions concerned about the impact on critical medical research advancements.